First China Pharmaceutical Group (FCPG) Return on Assets ROA from the third quarter of 2012 to third quarter of 2011 and for the year 2012, Average High and Low, Fundamental Ratios from Sep 30 2012 to Jun 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
First China Pharmaceutical Group, Inc.  (FCPG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


First China Pharmaceutical Group's ROA from the third quarter of 2012 to the third quarter of 2011 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is First China Pharmaceutical Group's ROA in the third quarter of 2012?
First China Pharmaceutical Group, Inc. achieved a return on average assets (ROA) of 15.37 % in its third quarter of 2012, this is above FCPG's average return on assets of 14.57%.
First China Pharmaceutical Group, Inc. assets over the 12 months ending in its third quarter of 2012 are valued at $19 million

ROA decreased relative to the period ending Jun 30 2012, due to the decline in net income.

However, within the Healthcare sector 21 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2012 from to 268.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Total Assets Change 0.84 % 26.44 % 75.43 % -12.34 % 249.95 %
Y / Y Net Income Change -42.62 % - - -5.27 % -
Net Income (TTM) in million 3 4 1 3 3
Return On Assets (TTM) 15.37 % 19.23 % 5.96 % 21.27 % 21.1 %
FCPG's Total Ranking # 268 # # # #
Total Assets (TTM) in million 19 20 28 10 19
Seq. Total Assets Change -2.15 % -29.21 % 193.31 % -50.37 % 22.69 %
Seq. Net Income Change -56.92 % - - -51.58 % -

FCPG's 5 Years Annual ROA >> Back to FCPG Management Effectiveness >> Compare FCPG ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 2
Sector # 22
Overall # 206

Return On Assets Statistics
High Average Low
14.57 %
14.57 %
14.57 %
(Sep 30 2012)  





Financial Statements
First China Pharmaceutical Group's Assets $ 19 million FCPG's Balance sheet
First China Pharmaceutical Group's Income $ 1 million Quarterly FCPG's Income Statement
FCPG's Income by Division See FCPG's Income by Division



Annual Return On Assets (Mar 31 2010)
FY 2011
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 6 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 3 0 0 0 0
Annual Return On Assets 50.05 % - - - -

FCPG's 5 Years Annual ROA >> Back to FCPG Management Effectiveness >> Compare FCPG ROA to its Competitors



Comment on FCPG's ROA in the fiscal year ending 2011
In the fiscal year 2011 ROA improved to 50.05 % compared to prior year, due to annual net income growth of % to $2.76 million, while value of First China Pharmaceutical Group's overall assets grew just by % to $5.52 million, compared to $5.52 a year before.


More Return On Assets Ratios
FCPG's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FCPG's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FCPG's Competitors
Subscribers only: Roa for First China Pharmaceutical Group's Suppliers
Subscribers only: Return On Assets for FCPG's Customers

You may also want to know
FCPG's Roi FCPG's Inventory Turnover Ratio FCPG's Growth Rates FCPG's Dividend Comparisons
FCPG's Profitability Ratios FCPG's Asset Turnover Ratio FCPG's Dividend Growth
FCPG's Roe FCPG's Valuation Ratios FCPG's Financial Strength Ratios FCPG's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2012, within Healthcare Sector ROA
Pacific Health Care Organization Inc  40.41 %
China Health Industries Holdings Inc   35.51 %
Lifevantage Corp  33.84 %
Fonar Corporation  25.78 %
Spectrum Pharmaceuticals Inc   24.93 %
Meridian Bioscience Inc   21.07 %
U S Physical Therapy Inc  18.93 %
Intuitive Surgical Inc   18.41 %
United Therapeutics Corporation  17.52 %
Idexx Laboratories Inc  17.08 %
Bio techne Corp  17.08 %
Nature s Sunshine Products inc   15.64 %
Regeneron Pharmaceuticals Inc   15.64 %
Celgene Corp  15.15 %
Biogen Inc   15.02 %
Waters Corporation  14.77 %
First China Pharmaceutical Group, Inc.  14.57 %
Utah Medical Products Inc  14.11 %
Varian Medical Systems Inc   13.92 %
Healthcare Services Group Inc   13.88 %
3m Company  13.47 %
Mettler toledo International Inc   13.44 %
Hca Healthcare Inc   13.35 %
Bard C R Inc  13.11 %
Biomerica Inc   13.03 %
Edwards Lifesciences Corporation  12.85 %
Gilead Sciences Inc   12.58 %
Eli Lilly And Company  12.48 %
Allergan plc  12.13 %
Icu Medical Inc  12.13 %

Date modified: 2026-09-08T15:07:17+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.